Decoy Therapeutics Inc. (DCOY) stock
DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.08 (-7.56%)
Close on Nov 13, 2026Market cap $638.94KP/E –Yield –
Decoy Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Decoy Therapeutics's profit margin for the twelve months ending Mar 31, 2022 was -2979.7%. For fiscal 2021 it was -693.8%, against -140.5% the year before. The highest annual figure on record is -85.6% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -693.8% | −553.4 |
| FY2020 | Dec 31, 2020 | -140.5% | +59.7 |
| FY2019 | Dec 31, 2019 | -200.2% | −114.6 |
| FY2018 | Dec 31, 2018 | -85.6% | +2616.2 |
| FY2017 | Dec 31, 2017 | -2701.7% | +1205.9 |
| FY2016 | Dec 31, 2016 | -3907.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -971.9% | −852.4 |
| Q2 FY2026 | Jun 30, 2026 | -1042.8% | −918.3 |
| Q2 FY2021 | Jun 30, 2021 | -538.1% | −394.5 |
| Q1 FY2021 | Mar 31, 2021 | -146.0% | +38.0 |
| Q4 FY2020 | Dec 31, 2020 | -119.5% | +61.8 |
| Q3 FY2020 | Sep 30, 2020 | -124.6% | +175.8 |
| Q2 FY2020 | Jun 30, 2020 | -143.5% | −42.6 |
| Q1 FY2020 | Mar 31, 2020 | -183.9% | +48.2 |
| Q4 FY2019 | Dec 31, 2019 | -181.3% | +1050.6 |
| Q3 FY2019 | Sep 30, 2019 | -300.3% | −234.8 |
| Q2 FY2019 | Jun 30, 2019 | -100.9% | −146.2 |
| Q1 FY2019 | Mar 31, 2019 | -232.2% | −18.5 |
| Q4 FY2018 | Dec 31, 2018 | -1231.9% | +1606.8 |
| Q3 FY2018 | Sep 30, 2018 | -65.5% | +2190.8 |
| Q2 FY2018 | Jun 30, 2018 | 45.3% | +2669.5 |
| Q1 FY2018 | Mar 31, 2018 | -213.7% | +3195.3 |
| Q4 FY2017 | Dec 31, 2017 | -2838.7% | −195.7 |
| Q3 FY2017 | Sep 30, 2017 | -2256.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -2624.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -3409.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -2643.0% | – |
See a number that looks wrong?